NERV
Minerva Neurosciences, Inc.NASDAQHealthcare$5.28-0.95%ClosedMarket Cap: $36.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.43
P/S
0.00
EV/EBITDA
-1.31
DCF Value
$1.98
FCF Yield
-39.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
506.7%
ROA
-299.5%
ROIC
-15.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-5.0M | $-283.7M | $-25.51 | — |
| FY 2025 | $0.00 | -Infinity% | $-15.1M | $-293.4M | $-34.67 | — |
| Q3 2025 | $0.00 | -Infinity% | $-2.8M | $-2.7M | $-0.36 | — |
| Q2 2025 | $0.00 | NaN% | $-3.4M | $-3.3M | $-0.43 | — |
| Q1 2025 | $0.00 | NaN% | $-3.9M | $-3.8M | $-0.50 | — |
| Q4 2024 | $0.00 | NaN% | $-4.5M | $-4.3M | $-0.56 | — |
| FY 2024 | $0.00 | NaN% | $-21.8M | $1.4M | $0.19 | — |
| Q3 2024 | $0.00 | NaN% | $-4.4M | $22.5M | $2.97 | — |
| Q2 2024 | $0.00 | NaN% | $-6.3M | $-8.2M | $-1.09 | — |
| Q1 2024 | $0.00 | NaN% | $-6.7M | $-8.6M | $-1.13 | — |
| Q4 2023 | $0.00 | NaN% | $-7.2M | $-9.0M | $-1.19 | — |
| FY 2023 | $0.00 | NaN% | $-23.1M | $-30.0M | $-4.61 | — |